These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 26417901
1. A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study. Pfaar O, van Twuijver E, Boot JD, Opstelten DJ, Klimek L, van Ree R, Diamant Z, Kuna P, Panzner P. Allergy; 2016 Jan; 71(1):99-107. PubMed ID: 26417901 [Abstract] [Full Text] [Related]
2. Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma. Pfaar O, Bachert C, Kuna P, Panzner P, Džupinová M, Klimek L, van Nimwegen MJ, Boot JD, Yu D, Opstelten DJE, de Kam PJ. J Allergy Clin Immunol; 2019 Mar; 143(3):970-977. PubMed ID: 30508538 [Abstract] [Full Text] [Related]
3. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit. Ellis AK, Tenn MW, Steacy LM, Adams DE, Day AG, Walker TJ, Nolte H. Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967 [Abstract] [Full Text] [Related]
4. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects. Ceuppens JL, Bullens D, Kleinjans H, van der Werf J, PURETHAL Birch Efficacy Study Group. Clin Exp Allergy; 2009 Dec; 39(12):1903-9. PubMed ID: 20085600 [Abstract] [Full Text] [Related]
8. Depigmented-polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients. Pfaar O, Biedermann T, Klimek L, Sager A, Robinson DS. Allergy; 2013 Oct; 68(10):1306-13. PubMed ID: 23991896 [Abstract] [Full Text] [Related]
9. Grass pollen allergoids conjugated with mannan for subcutaneous and sublingual immunotherapy: a dose-finding study. Ojeda P, Barjau MC, Subiza J, Moreno A, Ojeda I, Solano E, Alonso A, Caballero R, Del Pozo S, Gómez-Perosanz M, Sánchez-Trincado JL, Benito-Villalvilla C, Angelina A, Soria I, Reche PA, Palomares O, Subiza JL, Casanovas M. Front Immunol; 2024 Oct; 15():1431351. PubMed ID: 38989287 [Abstract] [Full Text] [Related]
10. Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study. Blome C, Hadler M, Karagiannis E, Kisch J, Neht C, Kressel N, Augustin M. Adv Ther; 2020 Jun; 37(6):2932-2945. PubMed ID: 32342352 [Abstract] [Full Text] [Related]
11. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis. Mäkelä MJ, Gyllfors P, Valovirta E, Steffensen MA, Grønager PM, Savolainen J, Winther L. Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533 [Abstract] [Full Text] [Related]
12. The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study. Bødtger U, Poulsen LK, Jacobi HH, Malling HJ. Allergy; 2002 Apr; 57(4):297-305. PubMed ID: 11906359 [Abstract] [Full Text] [Related]
13. Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid. Pfaar O, Hohlfeld JM, Al-Kadah B, Hauswald B, Homey B, Hunzelmann N, Schliemann S, Velling P, Worm M, Klimek L. Clin Exp Allergy; 2017 Nov; 47(11):1445-1455. PubMed ID: 28696503 [Abstract] [Full Text] [Related]
16. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects. Winther L, Malling HJ, Mosbech H. Allergy; 2000 Sep; 55(9):827-35. PubMed ID: 11003446 [Abstract] [Full Text] [Related]
17. A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study. Cirla AM, Cirla PE, Parmiani S, Pecora S. Allergol Immunopathol (Madr); 2003 Sep; 31(1):31-43. PubMed ID: 12573207 [Abstract] [Full Text] [Related]
18. The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trial. Biedermann T, Kuna P, Panzner P, Valovirta E, Andersson M, de Blay F, Thrane D, Jacobsen SH, Stage BS, Winther L. J Allergy Clin Immunol; 2019 Mar; 143(3):1058-1066.e6. PubMed ID: 30654054 [Abstract] [Full Text] [Related]
19. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. Pauli G, Larsen TH, Rak S, Horak F, Pastorello E, Valenta R, Purohit A, Arvidsson M, Kavina A, Schroeder JW, Mothes N, Spitzauer S, Montagut A, Galvain S, Melac M, André C, Poulsen LK, Malling HJ. J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581 [Abstract] [Full Text] [Related]
20. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial. Pfaar O, Wolf H, Klimek L, Schnitker J, Wüstenberg E. Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373 [Abstract] [Full Text] [Related] Page: [Next] [New Search]